Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab
NCT03306446
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
203
Enrollment
OTHER
Sponsor class
Conditions
CD
Interventions
DRUG:
Start adalimumab in monotherapy
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives